← Leaderboards
Crystal L Mackall
Clinical Sciences
$137,564
Attributed
$275,127
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $152.9K · FY2020–21$200K$150K$100K$50K$0
'20
'21
Funding mix
By agency
NIH$275,127 · 1
By mechanism
P01$275,127 · 1
Top collaborators
- John M Maris2 shared
Most similar at Clinical Sciences
Same institution · by research overlap
Others in their field
Other Emerging Leaders on “Clinical Trials”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$245,363,765
- Beth Baseler · Leidos Biomedical Research, Inc.$207,964,226
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$177,411,785
Research focus
Clinical TrialsApoptosisTumor AntigensNeoplasm /Cancer ImmunotherapyImmunoregulationAntigen Presenting CellTissue /Cell CultureOsteosarcomaT LymphocyteHuman SubjectClinical ResearchLeukocyte Activation /TransformationInterleukin 7Laboratory MouseInsightLaboratoriesMalignant NeoplasmsImmune SystemGleanHuman Therapy EvaluationBaseImmuneBladder NeoplasmCell Count
Grant awards (9)
Proj 4 - Enhancing the Potency and Durability of Immunotherapies$122,203
P01 · FY2021 · CA · contact PI
Proj 4 - Enhancing the Potency and Durability of Immunotherapies$152,924
P01 · FY2020 · CA · contact PI
Biology and Therapy of T Cell Depletion$984,566
Z01 · FY2007 · CA · contact PI
Biology and Therapy of T Cell Depletion$0
Z01 · FY2006 · SC · contact PI
Biology and Therapy of T Cell Depletion$0
Z01 · FY2005 · SC
Biology and Therapy of T Cell Depletion$0
Z01 · FY2003 · SC
Directing T Cell Responses during Immune Reconstitution$0
Z01 · FY2002 · SC
Directing T Cell Responses during Immune Reconstitution$0
Z01 · FY2001 · SC
Directing T Cell Responses during Immune Reconstitution$0
Z01 · FY2000 · SC